New therapy aims to curb youth suicide in ERs

NCT ID NCT06225661

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This trial tests a 6-week therapy program for youth (ages 12-17) who come to the emergency department with suicidal thoughts or behaviors. The program involves weekly sessions with a therapist for the teen and their family. Researchers want to see if this focused approach reduces suicide attempts and repeat ER visits compared to usual care. The study includes 330 participants across three Canadian hospitals.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
SAFE Intervention (a 6-week therapy program for youth and their families)
What this could lead to
If it works, this could provide an effective early intervention to reduce suicide attempts and hospital visits in high-risk youth.
What could go wrong
This is a relatively small trial (330 participants) and the intervention is behavioral, so results may vary and may not apply to all youth or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BEHAVIORAL SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavioral Symptoms Self-Injurious Behavior Suicidal Ideation Suicide Suicide Prevention Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alberta Children's Hospital - Alberta Health Services & University of Calgary

    Calgary, Alberta, T2W 1S7, Canada

  • McMaster Children's Hospital - Hamilton Health Sciences

    Hamilton, Ontario, L8L 8E7, Canada

  • The Hospital for Sick Children

    Toronto, Ontario, M5G 1X8, Canada

  • Trillium Health Partners

    Mississauga, Ontario, L5B 1B8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.